Catalase reverses tumorigenicity in a malignant cell line by an epidermal growth factor receptor pathway

Free Radical Biology and Medicine

Volumn 40, Issue 5, 2006, Pages 863-875

  Finch, Joanne S ^a   Tome, Margaret E ^b   Kwei, Kevin A ^c   Bowden, G Tim ^a,d  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

AP 1; Catalase; EGF R; Free radical; Protein tyrosine phosphatase; ROS; Tumorigenesis

Indexed keywords

CATALASE; EPIDERMAL GROWTH FACTOR RECEPTOR; HYDROGEN PEROXIDE; PROTEIN C FOS; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR AP 1; TYROSINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CELL ACTIVATION; CELL LINE; CELL PROLIFERATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; KERATINOCYTE; MOUSE; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; REPRESSOR GENE; SIGNAL TRANSDUCTION; TRANSGENE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CATALASE; CELL LINE, TUMOR; CELL PROLIFERATION; GENES, FOS; GENES, TUMOR SUPPRESSOR; HUMANS; HYDROGEN PEROXIDE; KERATINOCYTES; MICE; MICE, SCID; PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; RATS; REACTIVE OXYGEN SPECIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA;

EID: 33644641847     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2005.10.036     Document Type: Article

References (58)

1. F.Q. Schafer, and G.R. Buettner Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple Free Radic. Biol. Med. 30 2001 1191 1212
2. P.A. Cerutti Prooxidant states and tumor promotion Science 227 1985 375 381
3. G. Pagano, L.G. Korkina, U.T. Brunk, L. Chessa, P. Degan, D. del Principe, F.J. Kelly, W. Malorni, F. Pallardo, C. Pasquier, I. Scovassi, A. Zatterale, and C. Franceschi Congenital disorders sharing oxidative stress and cancer proneness as phenotypic hallmarks: prospects for joint research in pharmacology Med. Hypotheses 51 1998 253 266
4. Shacter, E.; Weitzman, S. A. Chronic inflammation and cancer. Oncology (Huntingt.). 16:217-226, 229; discussion 230-212; 2002.
5. L.A. Loeb A mutator phenotype in cancer Cancer Res. 61 2001 3230 3239
6. K.J. Davies Oxidative stress: the paradox of aerobic life Biochem. Soc. Symp. 61 1995 1 31
7. V.L. Kinnula, and J.D. Crapo Superoxide dismutases in malignant cells and human tumors Free Radic. Biol. Med. 36 2004 718 744
8. K. Irani, Y. Xia, J.L. Zweier, S.J. Sollott, C.J. Der, E.R. Fearon, M. Sundaresan, T. Finkel, and P.J. Goldschmidt-Clermont Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts Science 275 1997 1649 1652
9. P.H. Remans, S.I. Gringhuis, J.M. van Laar, M.E. Sanders, E.A. Papendrecht-van der Voort, F.J. Zwartkruis, E.W. Levarht, M. Rosas, P.J. Coffer, F.C. Breedveld, J.L. Bos, P.P. Tak, C.L. Verweij, and K.A. Reedquist Rap1 signaling is required for suppression of Ras-generated reactive oxygen species and protection against oxidative stress in T lymphocytes J. Immunol. 173 2004 920 931
10. R.H. Burdon Superoxide and hydrogen peroxide in relation to mammalian cell proliferation Free Radic. Biol. Med. 18 1995 775 794
11. H. Kamata, and H. Hirata Redox regulation of cellular signalling Cell. Signal. 11 1999 1 14
12. K. Faucher, H. Rabinovitch-Chable, G. Barriere, J. Cook-Moreau, and M. Rigaud Overexpression of cytosolic glutathione peroxidase (GPX1) delays endothelial cell growth and increases resistance to toxic challenges Biochimie 85 2003 611 617
13. J. Liu, M.M. Hinkhouse, W. Sun, C.J. Weydert, J.M. Ritchie, L.W. Oberley, and J.J. Cullen Redox regulation of pancreatic cancer cell growth: role of glutathione peroxidase in the suppression of the malignant phenotype Hum. Gene Ther. 15 2004 239 250
14. L. Policastro, B. Molinari, F. Larcher, P. Blanco, O.L. Podhajcer, C.S. Costa, P. Rojas, and H. Duran Imbalance of antioxidant enzymes in tumor cells and inhibition of proliferation and malignant features by scavenging hydrogen peroxide Mol. Carcinog. 39 2004 103 113
15. J.A. Melendez, R.P. Melathe, A.M. Rodriguez, J.E. Mazurkiewicz, and K.J. Davies Nitric oxide enhances the manganese superoxide dismutase-dependent suppression of proliferation in HT-1080 fibrosarcoma cells Cell Growth Differ. 10 1999 655 664
16. W. Zhong, L.W. Oberley, T.D. Oberley, and D.K. St Clair Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase Oncogene 14 1997 481 490
17. Y. Zhang, W. Zhao, H.J. Zhang, F.E. Domann, and L.W. Oberley Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth Cancer Res. 62 2002 1205 1212
18. M. Tanaka, K. Kogawa, K. Nakamura, Y. Nishihori, K. Kuribayashi, S. Hagiwara, H. Muramatsu, S. Sakamaki, and Y. Niitsu Anti-metastatic gene therapy utilizing subcutaneous inoculation of EC-SOD gene transduced autologous fibroblast suppressed lung metastasis of Meth-A cells and 3LL cells in mice Gene Ther. 8 2001 149 156
19. L.W. Oberley Mechanism of the tumor suppressive effect of MnSOD overexpression Biomed. Pharmacother. 59 2005 143 148
20. R.K. Boutwell The function and mechanism of promoters of carcinogenesis CRC Crit. Rev. Toxicol. 2 1974 419 443
21. A. Gupta, S.F. Rosenberger, and G.T. Bowden Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progressed mouse keratinocyte cell lines Carcinogenesis 20 1999 2063 2073
22. J.E. Strickland, D.A. Greenhalgh, A. Koceva-Chyla, H. Hennings, C. Restrepo, M. Balaschak, and S.H. Yuspa Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts Cancer Res. 48 1988 165 169
23. J.S. Finch, and G.T. Bowden PCR/RFLP assay for copy number of mutant and wild-type alleles Biotechniques 21 1996 1055 1060
24. K.A. Kwei, J.S. Finch, E.J. Thompson, and G.T. Bowden Transcriptional repression of catalase in mouse skin tumor progression Neoplasia 6 2004 440 448
25. A. Gupta, B. Butts, K.A. Kwei, K. Dvorakova, S.P. Stratton, M.M. Briehl, and G.T. Bowden Attenuation of catalase activity in the malignant phenotype plays a functional role in an in vitro model for tumor progression Cancer Lett. 173 2001 115 125
26. M.E. Tome, A.F. Baker, G. Powis, C.M. Payne, and M.M. Briehl Catalase-overexpressing thymocytes are resistant to glucocorticoid-induced apoptosis and exhibit increased net tumor growth Cancer Res. 61 2001 2766 2773
27. R.F. Beers Jr., and I.W. Sizer A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase J. Biol. Chem. 195 1952 133 140
28. B.D. Butts, K.A. Kwei, G.T. Bowden, and M.M. Briehl Elevated basal reactive oxygen species and phospho-Akt in murine keratinocytes resistant to ultraviolet B-induced apoptosis Mol. Carcinog. 37 2003 149 157
29. M. Gonzales, and G.T. Bowden Ultraviolet B (UVB) induction of the c-fos promoter is mediated by phospho-cAMP response element binding protein (CREB) binding to CRE and c-fos activator protein 1 site (FAP1) cis elements Gene 293 2002 169 179
30. C. Huang, J. Li, N. Chen, W. Ma, G.T. Bowden, and Z. Dong Inhibition of atypical PKC blocks ultraviolet-induced AP-1 activation by specifically inhibiting ERKs activation Mol. Carcinog. 27 2000 65 75
31. O. Myhre, J.M. Andersen, H. Aarnes, and F. Fonnum Evaluation of the probes 2′,7′-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation Biochem. Pharmacol. 65 2003 1575 1582
32. H. Wang, and J.A. Joseph Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader Free Radic. Biol. Med. 27 1999 612 616
33. H. Fujiki, M. Suganuma, A. Komori, J. Yatsunami, S. Okabe, T. Ohta, and E. Sueoka A new tumor promotion pathway and its inhibitors Cancer Detect. Prev. 18 1994 1 7
34. 2 mediates oxidative stress-induced epidermal growth factor receptor phosphorylation Toxicol. Lett. 122 2001 205 214
35. F. Antunes, and E. Cadenas Estimation of H2O2 gradients across biomembranes FEBS Lett. 475 2000 121 126
36. A. Levitzki, and A. Gazit Tyrosine kinase inhibition: an approach to drug development Science 267 1995 1782 1788
37. J.H. Song, M.S. Harris, and S.H. Shin Effects of fetal bovine serum on ferrous ion-induced oxidative stress in pheochromocytoma (PC12) cells Neurochem. Res. 26 2001 407 414
38. K.C. Ricart, and M.L. Fiszman Hydrogen peroxide-induced neurotoxicity in cultured cortical cells grown in serum-free and serum-containing media Neurochem. Res. 26 2001 801 808
39. M.C. Luna, S. Wong, and C.J. Gomer Photodynamic therapy mediated induction of early response genes Cancer Res. 54 1994 1374 1380
40. K.A. Kwei, J.S. Finch, J. Ranger-Moore, and G.T. Bowden The role of Rac1 in maintaining malignant phenotype of mouse skin tumor cells Cancer Lett. 2005
41. Y. Sun, L.W. Oberley, J.H. Elwell, and E. Sierra-Rivera Antioxidant enzyme activities in normal and transformed mouse liver cells Int. J. Cancer. 44 1989 1028 1033
42. A.M. Rodriguez, P.M. Carrico, J.E. Mazurkiewicz, and J.A. Melendez Mitochondrial or cytosolic catalase reverses the MnSOD-dependent inhibition of proliferation by enhancing respiratory chain activity, net ATP production, and decreasing the steady state levels of H(2)O(2) Free Radic. Biol. Med. 29 2000 801 813
43. E. Saez, S.E. Rutberg, E. Mueller, H. Oppenheim, J. Smoluk, S.H. Yuspa, and B.M. Spiegelman c-fos is required for malignant progression of skin tumors Cell 82 1995 721 732
44. R. Eferl, and E.F. Wagner AP-1: a double-edged sword in tumorigenesis Nat. Rev. Cancer 3 2003 859 868
45. F.E. Domann, J.P. Levy, M.J. Birrer, and G.T. Bowden Stable expression of a c-JUN deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice Cell Growth Differ. 5 1994 9 16
46. M. Ding, J.J. Li, S.S. Leonard, J.P. Ye, X. Shi, N.H. Colburn, V. Castranova, and V. Vallyathan Vanadate-induced activation of activator protein-1: role of reactive oxygen species Carcinogenesis 20 1999 663 668
47. P. Blume-Jensen, and T. Hunter Oncogenic kinase signalling Nature 411 2001 355 365
48. D.S. Salomon, R. Brandt, F. Ciardiello, and N. Normanno Epidermal growth factor-related peptides and their receptors in human malignancies Crit. Rev. Oncol. Hematol. 19 1995 183 232
49. A. Groen, S. Lemeer, T. van der Wijk, J. Overvoorde, A.J. Heck, A. Ostman, D. Barford, M. Slijper, and J. den Hertog Differential oxidation of protein-tyrosine phosphatases J. Biol. Chem. 280 2005 10298 10304
50. B. Markova, P. Gulati, P.A. Herrlich, and F.D. Bohmer Investigation of protein-tyrosine phosphatases by in-gel assays Methods 35 2005 22 27
51. S. Tomic, U. Greiser, R. Lammers, A. Kharitonenkov, E. Imyanitov, A. Ullrich, and F.D. Bohmer Association of SH2 domain protein tyrosine phosphatases with the epidermal growth factor receptor in human tumor cells. Phosphatidic acid activates receptor dephosphorylation by PTP1C J. Biol. Chem. 270 1995 21277 21284
52. A.J. Flint, T. Tiganis, D. Barford, and N.K. Tonks Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases Proc. Natl. Acad. Sci. USA 94 1997 1680 1685
53. A. Charest, J. Wagner, M. Kwan, and M.L. Tremblay Coupling of the murine protein tyrosine phosphatase PEST to the epidermal growth factor (EGF) receptor through a Src homology 3 (SH3) domain-mediated association with Grb2 Oncogene 14 1997 1643 1651
54. D.T. Kulas, B.J. Goldstein, and R.A. Mooney The transmembrane protein-tyrosine phosphatase LAR modulates signaling by multiple receptor tyrosine kinases J. Biol. Chem. 271 1996 748 754
55. E. Suarez Pestana, T. Tenev, S. Gross, B. Stoyanov, M. Ogata, and F.D. Bohmer The transmembrane protein tyrosine phosphatase RPTPsigma modulates signaling of the epidermal growth factor receptor in A431 cells Oncogene 18 1999 4069 4079
56. Y.S. Bae, S.W. Kang, M.S. Seo, I.C. Baines, E. Tekle, P.B. Chock, and S.G. Rhee Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation J. Biol. Chem. 272 1997 217 221
57. S.R. Lee, K.S. Kwon, S.R. Kim, and S.G. Rhee Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor J. Biol. Chem. 273 1998 15366 15372
58. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70